|
End-of-day quote
Korea S.E.
18/09/2026
|
5-day change | 1st Jan Change | ||
| 3,395.00 KRW | -3.41% |
|
+4.46% | -50.65% |
| 04-14 | Genome & Company announced that it has received KRW 6.99999414 billion in funding | CI |
| 04-03 | Genome & Company announced that it expects to receive KRW 6.99999414 billion in funding | CI |
Stock exchange
Korea S.E.
A314130 3,395.00 ₩
-3.41%
7.2B
₩
| Markets | Price | Change | Volumes | ||
|---|---|---|---|---|---|
| A314130 | 3,395.00KRW | -3.41% | 7.2B ₩ |
Quotes 5-day view: Genome & Company
End-of-day quote Korea S.E.| 14/09/2026 | 15/09/2026 | 16/09/2026 | 17/09/2026 | 18/09/2026 | |
|---|---|---|---|---|---|
| Last | ₩3,175.00 | ₩3,405.00 | ₩3,330.00 | ₩3,515.00 | ₩3,395.00 |
| Volume | 90,516 | 968,364 | 300,849 | 383,702 | 2,121,833 |
| Change | -2.31% | +7.24% | -2.20% | +5.56% | -3.41% |
| Opening | ₩3,320.00 | ₩3,285.00 | ₩3,410.00 | ₩3,345.00 | ₩3,455.00 |
| High | ₩3,320.00 | ₩3,475.00 | ₩3,525.00 | ₩3,595.00 | ₩3,515.00 |
| Low | ₩3,120.00 | ₩3,185.00 | ₩3,300.00 | ₩3,310.00 | ₩2,925.00 |
Performance
| 1 day | -3.41% | ||
| 1 week | +4.46% | ||
| Current month | -9.59% | ||
| 1 month | -19.74% | ||
| 3 months | -35.58% | ||
| 6 months | -61.20% | ||
| Current year | -50.65% | ||
| 1 year | +24.36% | ||
| 3 years | -55.91% | ||
| 5 years | -85.54% |
Volumes
marketsDaily volume
2,121,833
Avg. Volume 20 sessions
367,228
Avg. Volume 20 sessions KRW
1,246,739,060
Avg. Volume 20 sessions USD
900,145.6
Record volume 1
30,576,260
Record volume 2
14,495,024
Record volume 3
7,918,904
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Market Cap (KRW)
184,944,082,325
Market Cap (USD)
133,126,085
Net sales ()
24,586,847,080
Net sales (USD)
17,698,056
Free-Float
85.14%
Free-Float capitalization (KRW)
157,456,863,712
Free-Float capitalization (USD)
113,340,289
Average Daily Capital Traded
0.67%
Indicators
Moving average 5 days
3,364
Moving average 20 days
3,573
Moving average 50 days
3,737.3
Moving average 100 days
4,653.45
Price spread / (MMA5)
-0.91%
Price spread / (MMA20)
+5.24%
Price spread / (MMA50)
+10.08%
Price spread / (MMA100)
+37.07%
RSI 9 days
44.65
RSI 14 days
43.81
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -3.41% | +4.46% | +24.36% | -55.91% | 133M | ||
| +0.11% | +2.71% | +0.33% | +28.59% | 46.18B | ||
| -1.12% | +1.78% | +40.07% | +27.26% | 44.35B | ||
| -3.04% | -6.29% | +322.27% | +517.36% | 42.21B | ||
| -0.74% | +1.25% | +2.32% | +67.94% | 40.19B | ||
| -0.50% | +0.67% | +11.79% | +40.51% | 29.83B | ||
| -0.46% | +4.22% | +21.99% | +124.21% | 17.17B | ||
| -0.97% | -10.17% | - | - | 15.7B | ||
| -0.57% | +8.12% | +22.15% | +38.93% | 15.32B | ||
| -3.28% | -3.07% | -8.54% | -37.61% | 13.09B | ||
| Average | -1.40% | +1.32% | +48.53% | +83.48% | 26.42B | |
| Weighted average by Cap. | -1.11% | +0.85% | +66.20% | +122.89% |
Historical Quotes: Genome & Company
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
| 1 week | 2,925 | 3,595 | |
| 1 month | 2,925 | 4,520 | |
| Current year | 2,925 | 10,180 | |
| 1 year | 2,470 | 10,180 | |
| 3 years | 2,170 | 10,180 | |
| 5 years | 2,170 | 23,050 | |
| 10 years | 2,170 | 47,500 |
Monthly variations
Annual variations
| 2026 | -50.65% | ||
| 2025 | +150.18% | ||
| 2024 | -55.96% | ||
| 2023 | -28.42% | ||
| 2022 | -49.71% | ||
| 2021 | -56.35% | ||
| 2020 | +102.29% | ||
| 2019 | +219.51% | ||
| 2018 | +31.83% |
- Stock Market
- Stocks
- A314130 Stock
- Quotes Genome & Company
Select your edition
All financial news and data tailored to specific country editions
















